- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 19/00 - Hybrid peptides
Patent holdings for IPC class C07K 19/00
Total number of patents in this class: 10710
10-year publication summary
|
580
|
576
|
760
|
792
|
852
|
937
|
869
|
804
|
817
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19479 |
194 |
| The Trustees of the University of Pennsylvania | 4251 |
100 |
| The Board of Trustees of the Leland Stanford Junior University | 6226 |
70 |
| Acceleron Pharma Inc. | 373 |
69 |
| National Research Council of Canada | 1566 |
65 |
| The General Hospital Corporation | 4637 |
56 |
| Regeneron Pharmaceuticals, Inc. | 3974 |
56 |
| Osaka University | 3288 |
54 |
| F. Hoffmann-La Roche AG | 7942 |
52 |
| Chugai Seiyaku Kabushiki Kaisha | 1315 |
51 |
| JCR Pharmaceuticals Co., Ltd. | 218 |
49 |
| The University of Tokyo | 4051 |
49 |
| President and Fellows of Harvard College | 5904 |
47 |
| Board of Regents, The University of Texas System | 5604 |
45 |
| Immatics Biotechnologies GmbH | 1168 |
42 |
| The Johns Hopkins University | 5519 |
40 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
40 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2827 |
39 |
| Amgen Inc. | 3894 |
37 |
| Memorial Sloan-Kettering Cancer Center | 1883 |
37 |
| Other owners | 9518 |